Palisade Bio (PALI) Current Leases (2020 - 2025)
Palisade Bio (PALI) reported Current Leases of $24000.0 for Q2 2025, down 81.54% year-over-year from $130000.0 in Q2 2024, and down 58.62% quarter-over-quarter from $58000.0 in Q1 2025.
Palisade Bio (PALI) Current Leases (2020 - 2025) Analysis & Trends
Palisade Bio (PALI) has 6 years of Current Leases data on file, last reported at $24000.0 in Q2 2025.
- Current Leases for Q2 2025 came in at $24000.0, down 81.54% year-over-year; the trailing twelve-month figure through Jun 2025 was $24000.0 (down 81.54% YoY), and the FY2024 annual result was $90000.0, down 25.62% from the prior year.
- Current Leases fell to $24000.0 in Q2 2025 per PALI's latest filing, from $58000.0 in the prior quarter.
- Over five years, Current Leases peaked at $184000.0 in Q2 2021 and troughed at $24000.0 in Q2 2025.
- A 5-year average of $107764.7 and a median of $112000.0 in 2021 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases surged 67.69% in 2023, then sank 81.54% in 2025.
- A 5-year view of Current Leases shows it stood at $112000.0 in 2021, then slipped by 6.25% to $105000.0 in 2022, then grew by 15.24% to $121000.0 in 2023, then decreased by 25.62% to $90000.0 in 2024, then tumbled by 73.33% to $24000.0 in 2025.
- Business Quant data shows PALI's Current Leases at $24000.0 in Q2 2025, $58000.0 in Q1 2025, and $90000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Sep 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 184,000.00 |
| Dec 31, 2020 | 168,000.00 |